Method for producing an injectable medicament preparation

Details Method for producing an injectable medicament preparation Method for producing an injectable medicament preparation

2008-06-17

2008-06-17

Tate, Christopher (Department: 1654)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

C530S350000, C514S002600

Reexamination Certificate

active

07387771

ABSTRACT:
The invention relates to a method for producing injectable medicament preparations containing a therapeutically and/or diagnostically effective substance which is comprised of an active agent, of a spacer molecule and of at least one protein-binding molecule. After being brought into contact with the body, said therapeutically and/or diagnostically effective substance covalently bonds to the body fluid constituents or tissue constituents via the protein-binding molecules, thus providing a form of transport of the active agent that can be hydrolytically or enzymatically cleaved, according to pH, in the body while releasing the active agent.

REFERENCES:
patent: 5606017 (1997-02-01), Willner et al.
patent: 5622929 (1997-04-01), Willner et al.
patent: 5708146 (1998-01-01), Willner
patent: 196 36 889 (1998-03-01), None
patent: 199 23 168 (2000-11-01), None
patent: 0 554 708 (2005-05-01), None
patent: 00 76550 (2000-12-01), None
Kratz., et al “Preparation, Characterization and In Vitro . . . Doxorubicin”, Biological & Pharm. Bulletin, Pharm. Soc. of Japan, vol. 21, No. 1 , 1998, pp. 56-61.
A. Trouet, et al. “A covalent linkage between daunorubicin and proteins that is . . . in vivo studies”, Proceedings of the National Academy of Sciences of USA, vol. 79, 1 82 (pp. 626-629.
S. Netzel-Arnett, “Comparative Sequence . . . (Matrilysin”, Biochemistry, vol. 32, No. 25, 1993, pp. 6427-6432.
M. Nichifor et al: “Macromolecular prodrugs of 5-fluoroouracil . . . degradation”, Journal of Controlled release, vol. 39, 1996, pp. 79-92.
G. M. Dubowchik et al: “Cathepsin B-sensitive dipeptide prodrugs. 1. A model study . . . doxorubicin”, Biorg. Med. Chem. Lett. vol. 8. No. 23, pp. 3341-3346.
M. Kruger, et al: “synthesis and stability of four maleimide . . . chemoimmunoanjugates”, Biological & Pharm. Bull. of Japan, vol. 45, No. 2, 1997, pp. 399-401.
Beyer, et al., “Synthesis of New Bifunctional Maleimide Compounds for the Preparation of Chemoimmunoconjugates”,Monatshefte für Chemie128, pp. 91-102 (1997), Austria.
Kruüger, et al., “Synthesis and Stability of Four Maleimide Derivatives of the Anticancer Drug Doxorubicin for the Preparation of Chemoimmunoconjugates”,Chem. Pharm. Bull45(2) pp. 399-401 (1997).
Wilner, et al., “(6-Maleimidocaproyl)hydrazone of Doxorubicin-a New Derivative for the Preparation of Immunoconjugates of Doxorubicin”,Bioconjugate Chem. 1992, 4, pp. 521-527.

Affiliated with

Also associated with

Rating

Method for producing an injectable medicament preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for producing an injectable medicament preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing an injectable medicament preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2799628